| Dr Michael Edward Obrien, OD | |
|
1890 Goodman Rd E, Suite 100, Southaven, MS 38671-9552 | |
| (662) 772-5882 | |
| (662) 772-5808 |
| Full Name | Dr Michael Edward Obrien |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 31 Years |
| Location | 1890 Goodman Rd E, Southaven, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306925029 | NPI | - | NPPES |
| 09015435 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 593 (Mississippi) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Vision Center Pa | 2466692777 | 3 |
| Obrien Vision Center, P.a. | 6002990983 | 5 |
| Byhalia Vision Center Llc | 7517297591 | 4 |
News Archive
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.
Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
› Verified 3 days ago
| Provider Name | Obrien Vision Center, P.a. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1518046234 PECOS PAC ID: 6002990983 Enrollment ID: O20080303000142 |
News Archive
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.
Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
› Verified 3 days ago
| Provider Name | Charleston Vision Center Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932440138 PECOS PAC ID: 2466692777 Enrollment ID: O20130710000528 |
News Archive
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.
Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
› Verified 3 days ago
| Provider Name | Byhalia Vision Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952965022 PECOS PAC ID: 7517297591 Enrollment ID: O20190918002398 |
News Archive
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.
Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Edward Obrien, OD 1890 Goodman Rd E, Suite 100, Southaven, MS 38671-9552 Ph: (662) 772-5882 | Dr Michael Edward Obrien, OD 1890 Goodman Rd E, Suite 100, Southaven, MS 38671-9552 Ph: (662) 772-5882 |
News Archive
Despite 30 years of research, not a single therapy has been found to successfully delay or stop the progression of Parkinson's disease.
Researchers at Mayo Clinic, Harvard Medical School and the Massachusetts Institute of Technology are developing a biomaterial that has potential to protect patients at high risk for bleeding in surgery.
Surgical options for people with medical conditions including obesity, and the risks of operating on the elderly, feature among 10 new recommendations released today under the Choosing Wisely Australia initiative.
In a major breakthrough that comes after decades of research and nearly half a billion treatments in humans, scientists have finally unlocked how a key anti-parasitic drug kills the worms brought on by the filarial diseases river blindness and elephantitis.
› Verified 3 days ago
Dr. Heather Michelle Dowdy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 6811 Southcrest Pkwy, Southaven, MS 38671 Phone: 662-349-1920 Fax: 662-349-1995 | |
Obreineyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 354 Stateline Rd W, Southaven, MS 38671 Phone: 662-647-8707 Fax: 662-647-8706 | |
Parth Amin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 940 Church Rd W Ste C, Southaven, MS 38671 Phone: 662-331-3937 | |
Alan Charles Smith, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1228 Goodman Rd E Ste 1, Southaven, MS 38671 Phone: 662-349-8838 Fax: 662-349-8875 | |
Dr. Taylor Nicole Keys, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 7900 Airways Blvd Bldg A1, Southaven, MS 38671 Phone: 901-228-0092 | |
Eyear Optical Optometrist Medicare: Medicare Enrolled Practice Location: 3044 Goodman Rd E, Southaven, MS 38672 Phone: 662-349-1660 |